Abstract
Radiotherapy (RT) is a primary treatment modality for the majority of solid tumors. The objective is to destroy the tumor mass by exposure to ionizing radiation (IR) from an external beam or isotopic source. IR causes DNA damage directly and indirectly via the production of reactive oxygen intermediates (ROIs). Accumulation of sufficient damage leads to tumor cell death. The efficacy of RT is usually governed by the radiation dose given, the main limitation being the need to avoid injury to the surrounding normal tissues. To address the latter problem, physical techniques such as conformal and intensity-modulated radiotherapy have been developed to improve the precision of dose delivery to the tumor volume. However, some tumors prove refractory to conventional radiotherapy treatments, as insufficient dose can be delivered to the tumor. In such cases, other therapeutic strategies, such as chemotherapy, can be used in combination, particularly if such drugs lead to increased tumor radiosensitization. Nevertheless, many tumor types, (e.g., glioblastoma) are often resistant to even these combined approaches. Consequently, there is a need for new strategies that can improve the effectiveness of current radiotherapy regimens. Gene therapy offers the exciting possibility of significantly improving the efficacy of radiotherapy without the need for IR-dose escalation or undue increases in normal tissue morbidity. Furthermore, the potential to spatially and temporally target the activation of gene therapy vectors using clinically relevant IR doses provides a particularly attractive prospect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boothman, D. A., Bouvard, I., and Hughes, E. N. (1989) Identification and characterization of X-ray-induced proteins in human cells. Cancer Res. 49, 2871ā2878.
Fornace, A. J. (1992) Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev. Genet. 26, 507ā526.
Weichselbaum, R. R., Hallahan, D., Fuks, Z., and Kufe, D. (1994) Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Radiat. Oncol. Biol. Phys. 30(1), 229ā234.
Amundson, S. A., Do, K. T., and Fornace, A. J., Jr. (1999) Induction of stress genes by low doses of gamma rays. Radiat. Res. 152(3), 225ā231.
El-diery, W. S. Tokino, T., Velculescu, V. E., et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75(4), 817ā825.
Worthington, J. Robson, T., Murray, M., OāRourke, M., Keilty, G., and Hirst, D. G. (2000) Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther. 7, 1126ā1131.
Weichselbaum, R. R., Hallahan, D. E., Beckett, M. A., et al. (1994) Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res. 54, 4266ā4269.
Kastan, M. B., Zhan Q., el-Deiry, W. S., et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 71(4), 587ā597.
Gius, D., Cao, X., Rauscher, F. J., III, Cohen, D. R., Curran, T., and Sukhatme, V. P. (1990) Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol. Cell. Biol. 10(8), 4243ā4255.
Hallahan, D. E., Mauceri, H. J., Seung, L. P., et al. (1995) Spatial and temporal control of gene therapy using ionising radiation. Nature Med. 1(8), 786ā791.
Joki, T., Nakamura, M., and Ohno, T. (1995) Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum. Gene Ther. 6, 1507ā1513.
Mesnil, M. and Yamasaki, H. (2000) Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60, 3989ā3999.
Datta, R, Rubin, E., Sukhatme, V., et al. (1992) Ionizing radiation activates transcription of the Egr1 gene via CArG elements. Proc. Natl. Acad. Sci. USA 89, 10,149ā10,153.
Datta, R., Taneja, N., Sukhatme, V. P., Qureshi, S. A., Weichselbaum, R., and Kufe, D. W. (1993) Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 2419ā2422.
Sukhatme, V. P., Kartha, S., Toback, F. G., Taub, R., Hoover, R. G., and Tsai-Morris, C.-H. (1988) A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res. 1, 343ā355.
Tsai-Morris, C.-H., Cao, X., and Sukhatme, V. P. (1988) 5ā² Flanking sequence and genomic structure of Egr-1, a murine mitogen inducible zinc finger encoding gene. Nucleic Acids Res. 16(18), 8835ā8846.
Christy, B. and Nathans, D (1989) DNA binding site of the growth-factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA 86, 8737ā8741.
Sakamoto, K. M., Bardeleben, C., Yates, K. E., Raines, M. A., Golde, D. W., and Gasson, J. C. (1991) 5ā² Upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene 6, 867ā871.
Marples, B., Scott, S. D., Hendry, J. H., Embleton, M. J., Lashford, L. S., and Margison G. P. (2000) Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther. 7, 511ā517.
Scott, S. D., Marples, B., Hendry, J. H., et al. (2000) A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther. 7, 1121ā1125.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Scott, S.D., Marples, B. (2004). Radiation-Activated Antitumor Vectors. In: Springer, C.J. (eds) Suicide Gene Therapy. Methods in Molecular Medicineā¢, vol 90. Humana Press. https://doi.org/10.1385/1-59259-429-8:389
Download citation
DOI: https://doi.org/10.1385/1-59259-429-8:389
Publisher Name: Humana Press
Print ISBN: 978-0-89603-971-1
Online ISBN: 978-1-59259-429-0
eBook Packages: Springer Protocols